HROW
Harrow Health Inc
Price:  
28.07 
USD
Volume:  
245,609.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

HROW WACC - Weighted Average Cost of Capital

The WACC of Harrow Health Inc (HROW) is 8.5%.

The Cost of Equity of Harrow Health Inc (HROW) is 6.05%.
The Cost of Debt of Harrow Health Inc (HROW) is 20.45%.

Range Selected
Cost of equity 5.30% - 6.80% 6.05%
Tax rate 0.70% - 0.80% 0.75%
Cost of debt 17.00% - 23.90% 20.45%
WACC 7.3% - 9.7% 8.5%
WACC

HROW WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.3 0.35
Additional risk adjustments 0.0% 0.5%
Cost of equity 5.30% 6.80%
Tax rate 0.70% 0.80%
Debt/Equity ratio 0.21 0.21
Cost of debt 17.00% 23.90%
After-tax WACC 7.3% 9.7%
Selected WACC 8.5%

HROW's CAPM model and how its cost of Equity is calculated

The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.

This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.

Here’s how we figure out the cost of equity for HROW:

cost_of_equity (6.05%) = risk_free_rate (4.15%) + equity_risk_premium (5.10%) * adjusted_beta (0.3) + risk_adjustments (0.25%)

We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.